RECOMBINANT POLYCLONAL ANTIBODIES: SHOWCASING GRIFOLS' PROPRIETARY PLATFORM AS A CASE STUDY IN GAINING CAPABILITIES VIA EXTERNAL INNOVATION
 Tracks
		                    
			                    
				                    SEVERO OCHOA ROOM
			                    
	                    | Tuesday, October 7, 2025 | 
| 14:30 - 15:15 | 
| SEVERO OCHOA ROOM | 
Overview
                Sponsor GRIFOLS
            
        Details
                This session explores strategies used by the pharmaceutical industry to gain capabilities through external innovation, as well as approaches Biotechs companies use to expand via platform-based growth. Jose Terencio, SVP Discovery at Grifols, and Laia Crespo, Partner at Sanofi Ventures, will share their experience with strategic alignment, investment models, acquisition decisions, integration process and pipeline impact using Grifols' proprietary platform of recombinant polyclonal antibodies as a case study.
            
        Details
                        Grifols .
                    
                Sponsor
                        Dr Laia Crespo
                    
                
                            Partner
                        
                    
                            Sanofi Ventures
                        
                    Moderator
                        Dr Jose Terencio
                    
                
                            SVP Discovery
                        
                    
                            Grifols
                        
                    Speaker
